Emphysema News and Research

Latest Emphysema News and Research

Gene-chip studies provide new leads in treating abnormal lung development in premature newborns

Some 20 to 40 percent of extremely premature infants suffer abnormal lung development leading to bronchopulmonary dysplasia, a chronic lung disease that can cause long-term breathing problems.

4 Oct 2007

Stereotactic body radiation therapy reduces length of prostate cancer treatment

Breihan Bridgewater suffers from emphysema. He sleeps on his side because when he lays flat on his back it feels like there's a boulder resting on his chest.

20 Sep 2007

Link between nicotine and atherosclerosis

It's well known that smoking cigarettes increases risk for a host of serious health problems from cancer to heart disease. Now a new study from Weill Cornell Medical College in New York City looks at how they do their dirty work by contributing to atherosclerosis, or hardening of the arteries. The evidence points to nicotine, the addictive chemical in cigarettes.

11 Sep 2007

Breast implants and risk of suicide

Women who undergo breast augmentation surgery are nearly three times as likely to commit suicide, according to a study published in the August issue of Annals of Plastic Surgery .

8 Aug 2007

Potential new ways to prevent smoking-related cellular damage

In the current issue of PLoS One, researchers show how a poorly understood and previously unsuspected mechanism may be the key to understanding how life-style associated forms of oxidative stress, such as exposure to cigarette smoke, damage cells in the lungs.

7 Aug 2007

Sex and gender differences in chronic obstructive pulmonary disease

In the first study to directly compare men and women with chronic obstructive pulmonary disease, or COPD, and severe emphysema, researchers have found that there are marked differences between the sexes.

3 Aug 2007

One joint as bad as five cigarettes

The latest research says the effects of a single cannabis 'joint' could damage the lungs as much as smoking up to five tobacco cigarettes one after another.

31 Jul 2007

Some smokers have genetic predisposition to develop chronic obstructive pulmonary disease

Some people have a genetic variation that makes them more susceptible to chronic obstructive pulmonary disease (COPD) if they smoke tobacco, according to new research from Wake Forest University School of Medicine and colleagues.

12 Jul 2007

Acquired DNA key to certain bacterial infection

Researchers announced this week the discovery of a mechanism by which Mycobacterium avium - a bacterium which can result in serious lung infections and is prevalent in emphysema and AIDS patients among others - infects tissue cells or macrophages and thus compromises the body's immunity.

19 Jun 2007

People with chronic obstructive pulmonary disease have greater arterial stiffness

The researchers also found that those COPD patients with osteoporosis, a common complication of the respiratory disease, had even greater arterial stiffness. These premature signs of aging may explain why COPD patients are at greater risk for cardiovascular disease.

19 Jun 2007

Study of airway bypass treatment for emphysema

Researchers at Cedars-Sinai Medical Center announced today the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally-invasive option for those suffering with advanced widespread emphysema.

8 Jun 2007

Stroke victims could be more vulnerable to Alzheimer's

University of Leeds scientists have shown how stroke victims could be more vulnerable to Alzheimer's disease – years or even decades after making a full recovery.

5 Jun 2007

EASE - Exhale Airway Stents for Emphysema - trial

Researchers at Cedars-Sinai Medical Center have announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally-invasive option for those suffering with advanced widespread emphysema.

1 Jun 2007

Seniors and heart disease: Lower cholesterol, cut your risk

A new report from RetireSafe's Senior Center for Health and Security examines how statins can be an effective treatment for lowering cholesterol and cutting the overall risk of heart disease in America's seniors. among Americans.

24 May 2007

Clinical trial data for Perforomist Inhalation solution

Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).

22 May 2007

Mediterranean diet halves risk of chronic obstructive pulmonary disease

A Mediterranean diet halves the chances of developing progressive inflammatory lung disease (COPD), reveals a large study, published ahead of print in Thorax.

16 May 2007

FDA approves Dey, L.P.'s NDA for chronic obstructive pulmonary disease inhalation solution

Dey, L.P. has announced that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD).

15 May 2007

Mediterranean diet found to halve the risk for lung disease

French researchers say eating a Mediterranean diet halves the risk of serious lung disease such as emphysema and bronchitis.

15 May 2007

Infliximab fails to improve chronic obstructive pulmonary disease symptoms

A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multi-center trial.

2 May 2007

FDA advisory committee supports Advair 500/50 in reducing COPD exacerbations

An Advisory Committee to the Food and Drug Administration (FDA) has unanimously agreed that GlaxoSmithKline's Advair Diskus 500/50 (fluticasone propionate and salmeterol inhalation powder) demonstrated a significant reduction in the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the U.S.

2 May 2007